<DOC>
	<DOCNO>NCT02403908</DOCNO>
	<brief_summary>The aim research proposal ass compare safety efficacy radiofrequency denervation pulmonary artery decrease pulmonary vascular resistance mean pulmonary artery pressure ( MPAP ) 20 patient IPAH ( mean pulmonary artery pressure &gt; 25 mmHg ) 20 patient secondary pulmonary hypertension due pulmonary disease due leave heart disease respond optimally medical therapy .</brief_summary>
	<brief_title>Catheter Denervation Pulmonary Arteries Treatment IPAH &amp; SPAH</brief_title>
	<detailed_description>METHODS : Patient population . Patients IPAH SPAH ( define mean PAP &gt; 25 mm Hg rest ) respond optimally current medical therapy ( define reduction &lt; 5mmHg rest mean PAP medication , unchanged 6-min walk test ( 6MWT ) define increment 6MW distance &lt; 50 ) eligible study . The patient inform right withdraw inform consent time . After sign previously approve institutional write informed consent 20 patient proven IPAH 20 patient proven SPAH 20 control patient ( 10 IPAH 10 SPAH ) randomly assign radiofrequency denervation pulmonary artery sham group . Patients age &lt; 18 year , patient structural heart diseases left-to right shunt and/or Eisenmenger syndrome exclude trial . Medical treatment enrollment include diuretic sildenafil bosentan digoxin necessary medication discontinue . Blood sample obtain N-terminal brain natriuretic peptide ( NT-BNP ) , troponin T , mbCK , CK usually accept biological marker pulmonary hypertension level , immediately pulmonary artery denervation ( PADN ) procedure , 3 6 month follow PADN procedure . For assessment potential anatomical complication sight PADN multisliced compute tomography angiography pulmonary trunk pulmonary artery obtain 6 month PADN procedure . Assessment functional capacity ( 9 ) determine six-minutes walk test ( 6MWT ) , follow assessment dyspnea use Borg scale ( 10 ) . The 6MWT perform 3 month 6 month follow PADN procedure . The World Health Organization classification ( 11 ) rest exercise record physician blind study design . Echocardiography perform 3 month 6 month follow procedure . Echocardiographic study do use Vivid 7 ultrasound system standard image transducer ( General Electric Co. , Easton Turnpike , Connecticut ) . All measurement perform accord recommendation American Society Echocardiography ( 12 ) . Digital echocardiographic data contain minimum 3 consecutive beat ( 5 beat case atrial fibrillation ) acquire analyze . Right ventricular ( RV ) systolic pressure equal systolic PAP absence pulmonary stenosis . Systolic PAP equal sum right atrial ( RA ) pressure RV-to-RA pressure gradient systole . RA pressure estimate base echocardiographic feature inferior vena cava assign standard value ( 13 ) . The RV-to-RA pressure gradient calculate 4vt2 use modify Bernoulli equation , vt velocity tricuspid regurgitation jet m/s . The mean PAP estimate accord velocity pulmonary regurgitation jet m/s . The tricuspid excursion index ( Tei ) ( 14 ) define ( A-B ) /B , A time interval end onset tricuspid annular diastolic velocity , B duration tricuspid annular systolic velocity ( RV ejection time ) . PA compliance patient calculate stroke volume divide pulse pressure ( systolic PAP minus diastolic PAP ) . Hemodynamic measurement blood oxygen pressure/saturation determination RA , RV , PA perform previously describe use right heart catheterization immediately PADN procedure . These measurement repeat 24 h , 3 month 12 month . Measurements rest RA pressure , RV pressure , systolic/diastolic/mean PAP , PA occlusive pressure ( PAOP ) , cardiac output ( CO ) mix venous oxygen saturation record . The pulmonary vascular resistance ( PVR ) [ PVR ¼ ( mean PAP- PAOP ) /CO ] transpulmonary pressure gradient ( TPG ¼ mean PAP- PAOP ) calculate . All measurement record end expiration . Five criterion ( 15-17 ) use evaluate whether PAOP measurement valid : 1 ) PAOP le diastolic PAP ; 2 ) trace comparable atrial pressure waveform ; 3 ) fluoroscopic image exhibit stationary catheter follow inflation ; 4 ) free flow present within catheter ( flush test ) ; 5 ) highly oxygenate blood ( capillary ) obtain distal portion occlusion position . If PAOP measurement unreliable , leave ventricular end-diastolic pressure measure use rather PAOP . The blood sample superior vena cava PA obtain measurement oxygen pressure saturation . PADN procedure . A baseline PA angiography perform identify PA bifurcation level calculate PA diameter . An 8-F long sheath insert femoral vein advance main PA ( MPA ) . The PADN catheter advance along long sheath . After gently withdraw sheath push PADN catheter , tip release sheath . Then , slightly rotate push handle tip position first ostium leave PA ( Level 1 ablation , &lt; 2 mm distal orifice . After ablation level , catheter tip position ostium right PA ( Level 2 ablation , &lt; 2mm proximal bifurcation level ) . Finally , denervation main pulmonary artery do pull denervation catheter back Level 3 ablation ( &lt; 2 mm proximal ostia right leave PA-s ) main pulmonary artery.Three criterion use ensure electrode tightly contact endovascular surface : 1 ) strong manual resistance rotate handle ; 2 ) inability advance distally ease , withdraw proximally 3 ) angiographic confirmation 4 ) actual electrode contact pressure ( gm ) reading provide RF denervation system use . The procedure stop patient complain intolerable chest pain . The electrocardiogram hemodynamic pressure monitor continuously record throughout procedure . Procedural success define reduction mean PAP &gt; 10 mm Hg ( measure Swan-Ganz catheter ) , complication . The patient monitor intensive cardiac care unit least 24 h PADN procedure . Commercially available approve radiofrequency technology pulmonary vein isolation utilize new clinical indication . Peri-procedural medication . An intravenous bolus 5,000 U unfractionated heparin give immediately follow insertion venous sheath . An additional approximately 2,000 3,000 U heparin add procedural time exceed 1 h. Following procedure , oral warfarin prescribe adjust accord international normalized ratio 2 2.5 patient . If would contraindications warfarin , aspirin ( 100 mg/day ) clopidogrel ( 75 mg/day ) prescribe indefinitely . Immediately PADN procedure , medication ( diuretic , sildenafil , bosentan , beraprost , digoxin etc . ) discontinue 24h . Endpoints . The primary endpoint decrease mean PAP pulmonary vascular resistance 3 6 month improvement functional capacity 6MWT . Clinical adverse event ( include PA perforation/dissection , acute thrombus formation PA , all-cause death , rehospitalization due PAH , lung transplantation ) secondary endpoint assess independent event committee . Statistical analysis . Continuous variable express mean + SD . Differences continuous variable different time point PADN group analyze use paired-sample Student test Wilcoxon signed- rank sum test , appropriate nonparametric statistical method . Each patient trial serve his/her control PADN sham group patient control group overall efficacy procedure . The categorical variable compare use Fisher exact test . Statistical significance define 2-sided p value &lt; 0.05 . All analysis perform use WinStat statistical software package Microsoft Excel , version 2009 .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<criteria>Patients IPAH SPAH ( define mean PAP &gt; 25 mm Hg rest ) respond optimally current medical therapy ( define reduction &lt; 5mmHg rest mean PAP medication , unchanged 6min walk test ( 6MWT ) define increment 6MW distance &lt; 50 ) eligible study . Patients age &lt; 18 year , patient structural heart diseases leftto right shunt and/or Eisenmenger syndrome exclude trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>radiofrequency denervation , pulmonary hypertension</keyword>
</DOC>